Capsid protein and created a multiepitope vaccine candidate. Protein sequences of 42
strains of ASFV from 28 countries were selected. Binding to MHC proteins were predicted. T
and Linear B Lymphocytes epitopes were adopted and evaluated for antigenicity,
immunogenicity, allergenicity, and toxicity. Selected epitopes were modelled and
molecularly docked against the appropriate MHC proteins. An adjuvant and multiple linkers …